World Psoriasis Day - Case Study LEO Pharma
World Psoriasis Day 2014. LEO Pharma, in collaboration with Be Republic, decided to make something different to help increasing the awareness about Psoriasis...
By: LEOPharmaES
See the rest here:
World Psoriasis Day - Case Study LEO Pharma
World Psoriasis Day 2014. LEO Pharma, in collaboration with Be Republic, decided to make something different to help increasing the awareness about Psoriasis...
By: LEOPharmaES
See the rest here:
Get Ready With Me: Covering Psoriasis
My audio doesn #39;t transfer from my memory card to movie maker, so right now we #39;re stuck with watching me, instead of listening to me. Products used: EYES: Smashbox 24 Hour Eyeshadow Primer...
By: Liz Kurt
See the article here:
Psoriasis Diet Diary Week Eighteen
Week eighteen! A largely good week. A couple of areas worsening slightly specifically insides of elbows and inner thighs, I think this is down to the cold we...
By: Jon Maddison
View post:
Medicamentos biolgicos para la psoriasis
By: CM la noticia
See the original post:
Herbal Treatment #16 Psoriasis
Uploaded From Administration Herbal Treatment #16 Psoriasis Click on the link below to see more kinds of Illness and treatment Herbal Treatment https://www.y...
By: Shepherd Victor
More:
Psoriasis Complete Information What is Psoriasis Symptoms and Treatment Options
Learn How To Get Rid of Psoriasis Naturally in 3 Days. You Can Cure Psoriasis Fast, Safe Permanently at Home. CLICK HERE : http://Psoriasis-Natural-Remedies.com ...
By: Alternative Treatment Guide
Read the original:
Psoriasis Complete Information What is Psoriasis Symptoms and Treatment Options - Video
Psoriasis Diet Diary Week Seventeen
A good week! Improvements to arms, back and torso (as well as legs but I don #39;t document them for easiness). Big shout out to Freelee, check her channel out i...
By: Jon Maddison
See the original post:
This all natural product is really amazing finally a psoriasis product that really works!
Proven Psoriasis treatment with real results.
By: Loma Lux Laboratories
Original post:
This all natural product is really amazing finally a psoriasis product that really works! - Video
Treatment For Psoriasis How To Cure Psoriasis
By: Alternative Treatment Guide
The rest is here:
Solution For Psoriasis Problems | Review For Psoriasis | Homeopathy Treatment
Homeocare International is best homeopathic hospital in India. Dedicated doctors and friendly staff always treat as individually. Homeocare International pre...
By: Homeocare International Pvt Ltd
Read the rest here:
Solution For Psoriasis Problems | Review For Psoriasis | Homeopathy Treatment - Video
Exma Exema Eczema Ezcema Psoriasis treatment
Exma Exema Eczema Ezcema Psoriasis treatment, click here to be Eczema Free Forever! http://www.informati0n.com/eczema.php Many eczema patients are always complaining how to treat eczema ...
By: Ronnie Duran
The rest is here:
VLOG: House-husband? Good Ol #39; Psoriasis
Touching on doing laundry, work around the house, etc. Also, dealing with Psoriasis!
By: SilentFan85
View post:
Testimonio de MMS - Cancer y Psoriasis
Un testimonio de MMS desde la Iglesia Gnesis II sobre Cncer y Psoriasis. Fernando asisti el Seminario en Santa Marta y cont como encontr el MMS.
By: Testimonios de MMS
Continue reading here:
Psoriasis Revolution Review - Pathway to a Psoriasis-Free Life?
Psoriasis Revolution System and Review - http://prominentoffers.com/skin-care-recommendations/psoriasis-revolution-review/ Are you dealing with chronic psori...
By: ProminentOffers
The rest is here:
Psoriasis Revolution Review - Pathway to a Psoriasis-Free Life? - Video
You #39;ve Got This: Jon Maddison from United Kingdom (Psoriasis)
Having been approached by Healthline.com to produce a video for their #39;You #39;ve got this #39; campaign, this is the result! It #39;s a fantastic programme and is incre...
By: Jon Maddison
Read the original:
You've Got This: Jon Maddison from United Kingdom (Psoriasis) - Video
Novartis AG (NOVN) won U.S. approval for the first in a new line of psoriasis drugs that aim to better treat the itchy, sometimes debilitating skin condition.
The Food and Drug Administration cleared the treatment to be called Cosentyx. The medicine, also known as secukinumab, is predicted to top $1 billion in sales by 2020 and will compete with other biologic drugs including AbbVie Inc. (ABBV)s No. 1 seller, Humira, and Amgen Inc. (AMGN)s best-selling Enbrel. The therapy was backed in November by European Commission health regulators.
About 7.5 million Americans have psoriasis, which is an autoimmune disease that can cause raised, red patches on the skin that are covered in dead skin cells, according to the National Psoriasis Foundation. The new type of drugs called interleukin inhibitors block interaction with the IL-17A receptor, which triggers the inflammatory response that plays a role in the disease, the FDA said.
The FDAs approval of Cosentyx signifies a turning point for psoriasis patients, who can now benefit from the first and only approved treatment targeting the IL-17 pathway, David Epstein, division head of Novartis Pharmaceuticals, said in a statement.
Similar drugs are in development at Eli Lilly & Co. (LLY) and in a partnership of Amgen and AstraZeneca Plc. (AZN) The new therapies work faster and are expected to be more effective for the most serious patients.
Cosentyx is administered as an injection under the skin. It is intended for patients who are candidates for systemic therapy, treatment using substances that travel through the bloodstream, and ultraviolet light therapy, or a combination of both, the FDA said today in a statement.
The FDAs approval was based on four clinical trials that studied secukinumab against a placebo and found more patients on the drug had clear or almost clear skin, the agency said.
Novartis, based in Basel, Switzerland, also studied secukinumab against Thousand Oaks, California-based Amgens Enbrel and said it worked significantly better to clear the skin. The latest study pitting secukinumab against Johnson & Johnson (JNJ)s Stelara showed Novartiss drug worked better, the company said in a Dec. 12 statement.
Novartiss drug may generate $1.1 billion in annual sales in 2020, according to the average of seven analysts estimates compiled by Bloomberg. AbbVies Humira had an estimated $12.6 billion in sales in 2014 while Amgen and Pfizer Inc. are expected to report about $8.4 billion in Enbrel revenue.
Older treatments such as Enbrel and Humira block a protein called TNF that signals the body to create inflammation. Stelara targets proteins known as IL-12 and IL-23, while secukinumab goes after IL-17A, which only recently has been linked to psoriasis.
View original post here:
Novartis Wins U.S. Approval for First of New Psoriasis Drugs
Psoriasis Man Choreographed Dance Rehearsal
Psoriasis is NOT Contagious. But because of the lack of awareness, people shun us because they think we are. 1 in 100 Singaporeans suffer from an incurable a...
By: The Psoriasis Man Ray Chua
More here:
Psoriasis ,Ayurvedic view and Best Ayurvedic Treatment
Dr. Amit Dutta #39;s :: AYUR - SUDHA :: Advanced Ayurveda Skin Treatment centre is propagating all common to chronic Skin related disorders with authentic Ayurvedic , Herbal medicines and ...
By: AYUR -SUDHA :: Ayurvedic Skin Centre
Read the original post:
Psoriasis ,Ayurvedic view and Best Ayurvedic Treatment - Video
By RTT News, January 21, 2015, 08:42:00 PM EDT
(RTTNews.com) - Novartis AG ( NVS ) announced the US Food and Drug Administration has approved Cosentyx (secukinumab) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy, a drug that is absorbed into the bloodstream and distributed to all parts of the body, or phototherapy (light therapy).
Cosentyx is the first approved psoriasis medication to selectively bind to IL-17A and inhibit interaction with the IL-17 receptor.
The approval is based on the efficacy and safety outcomes from 10 Phase II and Phase III studies, including over 3,990 adult patients with moderate-to-severe plaque psoriasis, which demonstrated that Cosentyx resulted in clear or almost clear skin in the majority of patients and had an acceptable safety profile.
The FDA approval follows the unanimous vote by the FDA Advisory Committee in October 2014. Additionally, in January 2015, the European Commission (EC) approved Cosentyx as a first-line systemic treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy.
In addition to the US, Cosentyx has been approved in the EU and Australia for the treatment of moderate-to-severe plaque psoriasis and in Japan for the treatment of moderate-to-severe plaque psoriasis and active psoriatic arthritis (PsA).
In addition to psoriasis, Cosentyx is also in clinical trials for the treatment of PsA and ankylosing spondylitis (AS). Global regulatory applications for secukinumab in AS and PsA are planned for 2015.
For comments and feedback: contact editorial@rttnews.com
See the rest here:
Solucin Cura Problemas de la Piel: acne, caida del cabello,psoriasis,manchas,quemaduras
Solucion Definitiva tratamiento para la Piel :acne,Acn Hipertrofico (Nariz), Acn rosasea, caida del cabello, manos humedas (Hiperhidrosis),Mano seca ( Dishidrosis), ICTIOSIS, manchas oscuras...
By: Mundo Emprendedor TV
Here is the original post:
Solucin Cura Problemas de la Piel: acne, caida del cabello,psoriasis,manchas,quemaduras - Video